BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25524390)

  • 1. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.
    Sonawane KB; Qian J; Hansen RA
    Clin Ther; 2015 Jan; 37(1):188-96. PubMed ID: 25524390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
    J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.
    Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.
    Magvanjav O; Cooper-DeHoff RM; McDonough CW; Gong Y; Segal MS; Hogan WR; Johnson JA
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):91-101. PubMed ID: 30427124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of first-line antihypertensive drug classes on the maintenance of estimated glomerular filtration rate (eGFR) in real world primary care.
    Gao Q; Tan NC; Lee ML; Hsu W; Choo J
    Sci Rep; 2023 Dec; 13(1):21225. PubMed ID: 38040765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
    Brooks JM; Chapman CG; Suneja M; Schroeder MC; Fravel MA; Schneider KM; Wilwert J; Li YJ; Chrischilles EA; Brenton DW; Brenton M; Robinson J
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29848495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.
    Cataldi M; di Geronimo O; Trio R; Scotti A; Memoli A; Capone D; Guida B
    BMC Pharmacol Toxicol; 2016 Mar; 17():9. PubMed ID: 26980335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter?
    Mavridis D; Palmer SC; Strippoli GF
    Am J Kidney Dis; 2016 May; 67(5):713-5. PubMed ID: 27091011
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidiabetic drug use trends in patients with type 2 diabetes mellitus and chronic kidney disease: A cross-sectional analysis of the National Health and Nutrition Examination Survey.
    Gor D; Gerber BS; Walton SM; Lee TA; Nutescu EA; Touchette DR
    J Diabetes; 2020 May; 12(5):385-395. PubMed ID: 31652390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension.
    Mijinyawa Muhammad S; Yusuf MS; Mohammed H; Saidu H; Sulaiman BA; Uloko AE
    Niger J Med; 2016; 25(3):220-5. PubMed ID: 30011166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States.
    Murphy DP; Drawz PE; Foley RN
    J Am Soc Nephrol; 2019 Jul; 30(7):1314-1321. PubMed ID: 31167823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
    Chang TI; Zheng Y; Montez-Rath ME; Winkelmayer WC
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1401-1412. PubMed ID: 27354656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provision of care for chronic kidney disease by non-nephrologists in a developing nation: a national survey.
    Al Shamsi S; Al Dhanhani A; Sheek-Hussein MM; Bakoush O
    BMJ Open; 2016 Aug; 6(8):e010832. PubMed ID: 27481619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
    Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prevalence and treatment of hypertension in two populations in the United States: masters swimmers versus the NHANES population.
    Guthrie SK; Erickson SR; Lau MS
    J Sports Sci; 2013; 31(9):930-5. PubMed ID: 23305384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016.
    Santos D; Dhamoon MS
    JAMA Neurol; 2020 Nov; 77(11):1382-1389. PubMed ID: 32716495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.